The negative controls employed included adding no effector T cells, and adding effector T cells that were transduced with the 139 CAR that recognizes an irrelevant epitope [a glioma-specific variant of the epidermal growth factor receptor (80)]. The gene discussed is EGFR; the disease is glioma.